TIER - APhase I/II Study of Thiotepa, Ifosphamide, Etoposide & Rituximab for the treatment of relapsed & refractory primary central nervous system lymphoma

  • Siddique, Shamyla (Co-Investigator)
  • Jackson, Aimee (Principal Investigator)

Project Details

Short titleTIER - APhase I/II Study of Thiotepa, Ifosphamide, Etoposide & Rituximab for the treatment of relapsed & refractory primary central nervous system lymphoma
StatusFinished
Effective start/end date15/01/14 → 1/06/21

Funding

  • BLOODWISE